Colgate-Palmolive (NYSE:CL) PT Raised to $92.00

Colgate-Palmolive (NYSE:CL) had its price objective increased by equities researchers at Wells Fargo & Company from $90.00 to $92.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective indicates a potential upside of 2.07% from the stock’s previous close.

A number of other analysts also recently weighed in on the stock. TheStreet raised shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a research report on Friday, January 26th. Royal Bank of Canada boosted their target price on shares of Colgate-Palmolive from $88.00 to $95.00 and gave the stock a “sector perform” rating in a research report on Monday. Evercore ISI boosted their price objective on Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a report on Monday, April 8th. The Goldman Sachs Group started coverage on Colgate-Palmolive in a report on Friday, March 1st. They issued a “buy” rating and a $93.00 price target for the company. Finally, JPMorgan Chase & Co. increased their price target on Colgate-Palmolive from $88.00 to $90.00 and gave the stock an “overweight” rating in a research report on Thursday, January 18th. Three investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $91.38.

Colgate-Palmolive Trading Down 1.0 %

CL stock traded down $0.88 during trading on Monday, reaching $90.13. 2,385,562 shares of the stock traded hands, compared to its average volume of 4,581,458. The business’s 50 day moving average price is $87.66 and its 200-day moving average price is $81.63. The firm has a market capitalization of $74.09 billion, a PE ratio of 28.55, a P/E/G ratio of 3.42 and a beta of 0.42. The company has a debt-to-equity ratio of 8.59, a current ratio of 0.42 and a quick ratio of 0.28. Colgate-Palmolive has a 52-week low of $67.62 and a 52-week high of $92.25.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, beating analysts’ consensus estimates of $0.82 by $0.04. The firm had revenue of $5.07 billion for the quarter, compared to analysts’ expectations of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. Colgate-Palmolive’s revenue was up 6.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.73 earnings per share. As a group, sell-side analysts forecast that Colgate-Palmolive will post 3.5 earnings per share for the current year.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, Director C Martin Harris sold 2,760 shares of the stock in a transaction on Wednesday, January 31st. The stock was sold at an average price of $84.50, for a total transaction of $233,220.00. Following the completion of the transaction, the director now directly owns 19,272 shares of the company’s stock, valued at approximately $1,628,484. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Colgate-Palmolive news, Director C Martin Harris sold 2,760 shares of the stock in a transaction on Wednesday, January 31st. The stock was sold at an average price of $84.50, for a total transaction of $233,220.00. Following the completion of the transaction, the director now directly owns 19,272 shares of the company’s stock, valued at approximately $1,628,484. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Jennifer Daniels sold 3,538 shares of the firm’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total value of $299,562.46. Following the sale, the insider now directly owns 59,698 shares of the company’s stock, valued at $5,054,629.66. The disclosure for this sale can be found here. In the last ninety days, insiders sold 232,371 shares of company stock valued at $19,505,099. 0.37% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Colgate-Palmolive

Several large investors have recently modified their holdings of CL. Vest Financial LLC lifted its holdings in shares of Colgate-Palmolive by 25.1% in the fourth quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock valued at $29,498,000 after purchasing an additional 74,337 shares in the last quarter. Central Bank & Trust Co. lifted its holdings in shares of Colgate-Palmolive by 22.1% in the fourth quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock valued at $110,000 after purchasing an additional 250 shares in the last quarter. Dynamic Advisor Solutions LLC lifted its holdings in shares of Colgate-Palmolive by 9.2% in the fourth quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock valued at $864,000 after purchasing an additional 910 shares in the last quarter. Sarasin & Partners LLP lifted its holdings in shares of Colgate-Palmolive by 1.2% in the fourth quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock valued at $323,115,000 after purchasing an additional 49,980 shares in the last quarter. Finally, Cornerstone Wealth Management LLC lifted its holdings in shares of Colgate-Palmolive by 2.5% in the fourth quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock valued at $571,000 after purchasing an additional 172 shares in the last quarter. 80.41% of the stock is owned by institutional investors.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.